PPARG and endothelial dysfunction: Consistent with its activation by PPARγ, oral administration of the PPARγ agonist troglitazone augmented renal klotho mRNA expression in Otsuka Long–Evans Tokushima Fatty rats and protected against the endothelial dysfunction induced in this model of atherogenesis [62].